Misplaced Pages

Catherine M. Klapperich

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American biomedical engineer
This biography of a living person relies too much on references to primary sources. Please help by adding secondary or tertiary sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful.
Find sources: "Catherine M. Klapperich" – news · newspapers · books · scholar · JSTOR (June 2022) (Learn how and when to remove this message)

Catherine M. Klapperich is an American biomedical engineer noted for her research on diagnostics and precision medicine. She is currently a professor of biomedical engineering at Boston University, with additional appointments in materials science & engineering and mechanical engineering. Klapperich serves as the director of research for the DAMP Laboratory at BU. Klapperich was previously the director of the NIH NIBIB Center for Future Technologies in Cancer Care as part of the Point-of Care-Research Technologies Network.

Education and career

Klapperich earned her B.S. in materials science and engineering from Northwestern University; her M.S. in engineering sciences from Harvard University; and, Ph.D. in mechanical engineering from the University of California, Berkeley with Lisa Pruitt. Klapperich did her doctoral studies on plasma treatment of biomaterials and nanoengineering for medical applications. Before joining the faculty at Boston University, Klapperich was a postdoctoral fellow at Lawrence Berkeley Laboratory working with Carolyn Bertozzi, and a senior research scientist at Aclara Biosciences in Mountain View, California.

Klapperich's research is focused on engineering medical devices for use in low resource settings and at the point of care. Research focuses on use of disposable microfluidic diagnostics that incorporate on-board sample preparation and minimally instrumented devices to enable molecular testing for cancer, women's health and sexually transmitted diseases. Klapperich and colleagues founded a startup company, Jane Diagnostics, that received start-up funding to commercialize these technologies.

During the global pandemic in 2020, Klapperich built the campus-wide testing laboratory for COVID-19 at Boston University.

Honors and awards

Some of Klapperich's honors have included:

References

  1. "Point-of-Care Research Technologies Network".
  2. Raven, Kathleen (June 11, 2012). "Microfluidic chips offer a SMART-er way to detect flu". Spoonful of Medicine. Nature Medicine.
  3. Staff reporter (Feb 22, 2022). "Jane Technologies receives grant for endometriosis test development".
  4. "COVID-19 Clinical Testing". Birx visits BU COVID-19 clinical testing lab.
  5. AIMBE College of Fellows Class of 2014
  6. BMES List of Fellows
  7. AAAS List of Fellows
  8. "Klapperich Elected to BBJ's Power 50 for 2020". BU College of Engineering. Retrieved 22 June 2022.

External links

Categories: